Weight Loss Peptides

This category features research peptides studied in the context of metabolic function, energy homeostasis, and body composition regulation. These compounds are investigated in preclinical and cellular research settings examining GLP-1 receptor pathways, lipid metabolism, and insulin signaling.
Featured compounds include:

AOD-9604 — A modified fragment of human growth hormone studied in fat metabolism research
HGH Fragment 176-191 — A synthetic peptide studied in lipolysis research contexts
Retatrutide — A triple receptor agonist (GLP-1/GIP/glucagon) studied in metabolic research
Cagrilintide — An amylin analog studied in energy balance research
Mazdutide / Survodutide — GLP-1 receptor agonists studied in metabolic disease research
Exenatide / Lixisenatide / Dulaglutide — GLP-1 analog compounds studied in receptor biology research

All compounds are strictly for laboratory research use only. These compounds are not approved for weight loss, human consumption, or clinical use.